Your browser doesn't support javascript.
loading
Immunogenicity and safety of two novel human papillomavirus 4- and 9-valent vaccines in Chinese women aged 20-45 years: A randomized, blinded, controlled with Gardasil (type 6/11/16/18), phase III non-inferiority clinical trial.
Shu, Yajun; Yu, Yebin; Ji, Ying; Zhang, Li; Li, Yuan; Qin, Haiyang; Huang, Zhuhang; Ou, Zhiqiang; Huang, Meilian; Shen, Qiong; Li, Zehong; Hu, Meng; Li, Chunyun; Zhang, Gaoxia; Zhang, Jikai.
Afiliação
  • Shu Y; Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou 510440, China.
  • Yu Y; Yangchun Center for Disease Control and Prevention, Guangdong 52960, China.
  • Ji Y; Bovax Biotechnology Co., Ltd., Shanghai 201321, China.
  • Zhang L; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC) and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Beijing 100081, China.
  • Li Y; Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou 510440, China.
  • Qin H; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC) and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Beijing 100081, China.
  • Huang Z; Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou 510440, China.
  • Ou Z; Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou 510440, China.
  • Huang M; Yangchun Center for Disease Control and Prevention, Guangdong 52960, China.
  • Shen Q; Bovax Biotechnology Co., Ltd., Shanghai 201321, China.
  • Li Z; Bovax Biotechnology Co., Ltd., Shanghai 201321, China.
  • Hu M; Bovax Biotechnology Co., Ltd., Shanghai 201321, China.
  • Li C; Bovax Biotechnology Co., Ltd., Shanghai 201321, China.
  • Zhang G; Chongqing Bovax Biopharmaceutical Co., Ltd., Chongqing 401338, China. Electronic address: zhanggaoxia@bovax.com.cn.
  • Zhang J; Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou 510440, China. Electronic address: gdswyw_sps@cdcp.org.cn.
Vaccine ; 40(48): 6947-6955, 2022 11 15.
Article em En | MEDLINE | ID: mdl-36283897
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Infecções por Papillomavirus / Vacinas contra Papillomavirus Tipo de estudo: Clinical_trials Limite: Female / Humans País/Região como assunto: Asia Idioma: En Revista: Vaccine Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Infecções por Papillomavirus / Vacinas contra Papillomavirus Tipo de estudo: Clinical_trials Limite: Female / Humans País/Região como assunto: Asia Idioma: En Revista: Vaccine Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China